Central Institute for Medicinal and Aromatic Plants

The Central Institute for Medicinal and Aromatic Plants, widely known as CIMAP or CSIR-CIMAP, is an Indian public-sector research institute operating under the Council of Scientific and Industrial Research. Its work is centered on medicinal and aromatic plants, commonly abbreviated as MAPs, and spans biological sciences, chemical sciences, agronomy, plant improvement, biotechnology, post-harvest processing, essential oils, and the development of technologies that can be transferred to farmers and entrepreneurs. The institute originated in the policy environment of the 1950s, when Indian scientific and agricultural bodies sought a coordinated national approach to medicinal-plant research. CSIR approved the creation of the Central Indian Medicinal Plants Organisation, or CIMPO, in 1957. The organization began functioning on 26 March 1959, with P. M. Nabar as its first officer in charge. Its original remit was to coordinate existing work, develop India's medicinal-plant resources, bring commercially important plants under cultivation, and introduce high-yielding exotic species where appropriate. Aromatic plants were included because their cultivation and research requirements substantially overlapped with those of medicinal plants. CIMPO also absorbed activities previously associated with CSIR's Essential Oils Research Committee. The organization was subsequently developed into the Central Institute of Medicinal and Aromatic Plants. It is headquartered in Lucknow and maintains research centres in Bengaluru, Hyderabad, Pantnagar, and Purara. The geographically distributed network allows the institute to test plants and cultivation methods in different agro-climatic conditions rather than relying on a single research location. A Hyderabad branch was established in 1982. CIMAP's activities are not limited to laboratory research. The institute releases plant varieties, develops complete or partial agro-technological packages, supports propagation and cultivation, and works on harvesting, processing, and post-harvest handling. Its mint research has been especially influential: varieties and production packages associated with CIMAP helped India become a leading global producer of mint and mint-related industrial products. The institute's broader role is to connect publicly funded science with agricultural production, industrial raw materials, natural-product chemistry, and commercial products derived from medicinal and aromatic plants. The institute also participates in international research and technology cooperation. It has entered into scientific collaboration arrangements with Malaysia covering research, development, and commercialization related to MAP technologies. In February 2024, CIMAP announced plans for a unit devoted to developing a synthetic-biology platform for high-value phytomolecules. That initiative reflects the institute's continuing effort to combine conventional plant science with modern biotechnology and to address the supply, consistency, and commercial production of valuable plant-derived molecules. CIMAP is therefore best understood not as a consumer-facing product brand, but as a public research and technology-transfer institution. Its institutional outputs include improved plant varieties, cultivation and post-harvest methods, scientific knowledge, training and technical services, collaborations, and technologies intended for adoption by farmers, processors, and businesses.

CIMAP emerged from India's post-independence effort to organize medicinal-plant research on a national basis. In 1957, the Council of Scientific and Industrial Research approved the establishment of the Central Indian Medicinal Plants Organisation. The proposed organization was intended to coordinate work already being conducted by agricultural, medical, governmental, and academic bodies; expand the country's medicinal-plant resources; promote cultivation of plants in high demand; and introduce promising exotic species with useful active constituents. The scope was soon understood to include aromatic plants as well. Their cultivation, essential-oil production, agronomy, and processing overlapped sufficiently with medicinal-plant work that aromatic species were incorporated into the organization's mandate. The Essential Oils Research Committee associated with CSIR was dissolved, and its activities were transferred to CIMPO. The organization formally began operations on 26 March 1959 under its first officer in charge, P. M. Nabar. Over time, CIMPO developed into the Central Institute for Medicinal and Aromatic Plants, now commonly identified as CIMAP or CSIR-CIMAP. The institute became headquartered in Lucknow and established research centres in several distinct agricultural and climatic regions of India. These facilities include centres in Bengaluru, Hyderabad, Pantnagar, and Purara. The multi-location structure supports field trials and research on plants whose growth, yield, and active constituents vary according to climate, soil, and cultivation practice. The Hyderabad branch was established on 7 July 1982. CIMAP's institutional model combines basic and applied research. Its scientific work covers biological and chemical disciplines, plant improvement, cultivation systems, essential oils, phytochemistry, biotechnology, and post-harvest practices. Rather than treating research outputs as purely academic, the institute has sought to provide farmers and entrepreneurs with practical technologies and services. These include improved varieties, propagation and cultivation guidance, agro-packages, processing methods, and information intended to support commercial MAP production. Mint research became one of CIMAP's most visible areas of impact. The institute released mint varieties and developed cultivation and post-harvest packages that contributed to the expansion and modernization of India's mint sector. These efforts helped India attain a leading position in global mint production and in industries using mint-derived materials. The institute later extended its activities through international scientific cooperation. Collaboration agreements with Malaysia have addressed research, development, and commercialization of medicinal- and aromatic-plant technologies. In February 2024, CIMAP announced plans for a synthetic-biology platform aimed at high-value phytomolecules. This direction indicates a continuing shift toward advanced methods for producing, studying, and commercializing valuable compounds associated with medicinal plants. Today, CIMAP remains part of CSIR's network of national laboratories. Its role combines plant and chemical science, agricultural development, technology transfer, and support for value chains based on medicinal and aromatic plants.

• 2024

  Synthetic-biology platform announced

  [1]Central Institute of Medicinal and Aromatic Plantsen.wikipedia.org

  CIMAP announced a planned unit for developing a synthetic-biology platform focused on high-value phytomolecules.

• 1982

  Hyderabad branch established

  [1]Central Institute of Medicinal and Aromatic Plantsen.wikipedia.org

  CIMAP established its Hyderabad branch on 7 July 1982, expanding its multi-location research network.

• 1959

  CIMPO begins operations

  [1]Central Institute of Medicinal and Aromatic Plantsen.wikipedia.org

  The Central Indian Medicinal Plants Organisation began functioning on 26 March 1959, with P. M. Nabar serving as its first officer in charge.

• 1957

  CSIR approves creation of CIMPO

  [1]Central Institute of Medicinal and Aromatic Plantsen.wikipedia.org

  The Council of Scientific and Industrial Research approved a national organization intended to coordinate medicinal-plant research and promote cultivation and resource development.

A publicly funded Indian research and technology-transfer institution focused on improving the science, cultivation, processing, and commercialization of medicinal and aromatic plants.

• Agricultural varieties and agro-technology

  Mint varieties and production packages

  CIMAP has released mint varieties and developed cultivation, agronomic, and post-harvest packages for the crop. These outputs support more productive and commercially consistent mint cultivation and have contributed to India's importance in global mint production and mint-derived industrial products.

• Agricultural and processing technology

  Medicinal and aromatic plant technologies

  The institute develops and disseminates technologies covering the selection, cultivation, harvesting, processing, and post-harvest handling of medicinal and aromatic plants. The intended users include farmers, processors, entrepreneurs, and organizations developing plant-based products.

• Biotechnology research · 2024

  Phytomolecule research platforms

  CIMAP's research includes the study and development of valuable compounds from plants. Its announced synthetic-biology initiative is intended to create a platform for work on high-value phytomolecules using advanced biological production and research methods.

• 2024

  Plan to establish a synthetic-biology unitStrategy

  Background

  CIMAP identified advanced biotechnology as a route to research and develop high-value phytomolecules associated with medicinal plants.

  Action taken

  The institute announced plans for a dedicated unit and synthetic-biology platform focused on high-value phytomolecules.

  Aftermath

  The available reference material records the announcement but does not provide details on implementation, funding, or later operating results.

  Source

1. 1Central Institute of Medicinal and Aromatic Plantsen.wikipedia.org
2. 2CIMAP official websitecimap.res.in